IL6 and cancer: As increased IL-6 trans-signaling in 4T1 cell-bearing mice was suggested to occur in the primary tumor sites and metastatic lung (Figure 3E), we evaluated whether increased IL-6 trans-signaling in the lung also affected the efferent phase of cancer cell metastasis.